First US death from covid-19

[mrisha]

My issue with China is why didn't they stop all transportation out of their country when they discovered Covid-19?  If they had  done their job, we would not have to stress ourselves because of their lack of handling the situation correctly.  Now we have some many people afraid to leave their home or go out anywhere.  This is too much for people to handle.

[calendria]

 

 

Coronavirus Vaccines — Precision Vaccinations


https://www.precisionvaccinations.com/vaccines/coronavirus-vaccines

Mar 10, 2020 · Coronavirus Vaccine Candidates Conducting Human Clinical Trials: INO-4700 MERS-CoV is a DNA plasmid vaccine that expresses the MERS CoV spike (S) glycoprotein. Inovio expects to advance INO-4700 into a Phase 2 field study in the Middle East and Africa where outbreaks have been observed, with full funding from CEPI.

Coronaviruses without preventive vaccines are the Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV), and the novel coronavirus SARS-CoV-2, which causes COVID-19 disease in humans.
There are 5 approaches currently being taken by various organizations deploying different technologies to develop a vaccine against SARS-CoV-2. As of March 13, 2020, the US Food and Drug Administration has not approved any preventive or therapeutic vaccines for use against the SARS, MERS or SARS-CoV-2 coronaviruses.

INO-4800 DNA Coronavirus Vaccine - March 12, 2020 - INOVIO Pharmaceuticals, Inc. announced that it has received a new $5 million grant from the Bill & Melinda Gates Foundation to accelerate the testing and scale-up of CELLECTRA® 3PSP proprietary smart device for the intradermal delivery of INO-4800, a DNA vaccine for COVID-19 disease.

[calendria]

 

 

I found this site off another survey platform and it has interesting topics for everything health and wellness related.  Must see:

https://thirdage.com/a-5-step-coronavirus-survival-plan-for-seniors/

thirdAGE.com is a premier health and wellness site targeted to women of all ages and their families. Healthy living matters more than ever—and women don’t just take care of themselves, they care for their family’s health too. When it comes to health decisions—they make 80% of them. thirdAGE provides thoughtfully curated health and lifestyle content, offering a full-range of interactive up-to-the-moment information —including video, slideshows, health condition centers, articles about cutting-edge research and more—all medically reviewed and approved by our team of thirdAGE physicians.

The thirdAGE audience is growing exponentially and provides a powerful platform for building health and wellness awareness for this empowered group of women.

https://thirdage.com/             very nice website for information, good job!

[calendria]

 

This was a surprise, worked for Ebola maybe it would pull Coronaviruses out too!


Hemopurifier made of protein mesh material attaches to a dialysis machine - The specially designed filter is made of a protein that acts as glue for proteins found on the Ebola virus surface. Over a period of 6.5 hours, the filter extracted the virus from the blood that flows through. While most dialysis filters can pull out molecules that are less than 4 nanometers in diameter, the virus filter boasts a mesh that’s able to filter out larger viral particles that are less than 250 nanometers. That means only the virus is pulled out, and the immune cells remain in the blood, ready to fight off any remaining viral invaders.

RELATED STORIES


https://time.com/3586271/ebola-treatment-dialysis-blood/



That’s when Geiger recalled reading about a novel way of treating viruses that didn’t involve drugs. Aethlon Medical, a California-based company, was testing a way to quite literally filter viruses out of the blood of infected patients. The team had been testing their device, which attached to standard kidney dialysis machines, on hepatitis C and HIV patients in India. The German doctors, desperate to help their patient, asked to test it for Ebola.

“We had no [idea] about how much [virus] would be extracted, because this was the first patient, but I was very surprised because the drop in viral load was deeper than I expected,” says Geiger. Before the filtration began, the patient’s virus count was about 400,000 per mL blood. After the session it had dropped to 1,000 copies/mL.

What’s more, when Geiger’s team sent the filter, which was designed to safely contain the Ebola virus it had extracted, to the University of Marburg, which has a biosafety level 4 laboratory for safely handling the virus, they learned that the device had managed to trap 242 million copies of the virus.

Freed from that viral burden, the patient soon began to improve rapidly. His own immune system began fighting off the remaining virus, and he no longer needs dialysis or a ventilator. The patient is walking and waiting to be released from the hospital.

Geiger stresses that it’s not clear yet whether the Hemopurifier alone was responsible for the patient’s recovery, since he was given other experimental therapies, but the amount of virus removed from his body and his rapid recovery after the filtration suggests that it at least played a role in helping him survive his infection.

While puling viruses out of infected individuals has never been tried before, Geiger believes it will be an important strategy for treating not just Ebola but other viral infections as well, including HIV, hepatitis and even influenza. “It’s a very interesting concept. The big advantage is that the plasma is filtered, and only the virus is removed and the other plasma components like immune cells go back to the patient. That’s important because with viral infections, the patient is in a reduced immune situation.”

The device works with most standard kidney dialysis machines, so Geiger says most hospitals would have no problem using it. And his team have worked out the mechanics of setting the blood flow to the proper levels to ensure the filter works at its best. “We have all the data that could be applied at other centers and for other users of the device,” he says.

UPDATE:

The Hemopurifier® in Infectious Disease :: Aethlon Medical ...

https://www.aethlonmedical.com/the-hemopurifier

The Hemopurifier® in Infectious Disease. We’re Developing Medical Countermeasures with Broad-Spectrum Capabilities Statement regarding Aethlon’s position with respect to the potential for use of the Hemopurifier as a countermeasure against the current coronavirus SARS-CoV-2 (COVID-19) outbreak.

[vg7405]

I hope and pray that this pandemic dies down very soon. I just learned that one of my relatives tested positive for the virus.

I have had to work remotely from home over the past two weeks. While I enjoy the time away from work, I am understandably not happy with the circumstances which led to my tele-working.

[calendria]

 
 

Tyson will reopen Waterloo plant where hundreds sickened

https://apnews.com/db0055d9b08c05193d1fe81c5c6fc46f

May 06, 2020 · Tyson will reopen Waterloo plant where hundreds sickened May 6, 2020 GMT WATERLOO, Iowa (AP) — Tyson Foods will begin limited operation Thursday of its huge pork processing plant in Waterloo, more than two weeks after closing the facility because of a coronavirus outbreak among workers, the company announced Tuesday.



[A mutant coronavirus has emerged, even more contagious ...

https://www.ajc.com/news/mutant-coronavirus-has-emerged-even-more-contagious-than-the-original-study-says/hie7CwOfn0AWHQcPAQsNiN/ftp://

Scientists have identified a new strain of the coronavirus that has become dominant worldwide and appears to be more contagious than the versions that spread in the early days of the COVID-19.

The new strain appeared in February in Europe, migrated quickly to the East Coast of the United States and has been the dominant strain across the world since mid-March, the scientists wrote. In addition to spreading faster, it may make people vulnerable to a second infection after a first bout with the disease, the report warned. The 33-page report was posted Thursday on BioRxiv, a website that researchers use to share their work before it is peer reviewed, an effort to speed up collaborations with scientists working on COVID-19 vaccines or treatments. That research has been largely based on the genetic sequence of earlier strains and might not be effective against the new one. The mutation identified in the new report affects the now infamous spikes on the exterior of the coronavirus, which allow it to enter human respiratory cells. The report's authors said they felt an "urgent need for an early warning" so that vaccines and drugs under development around the world will be effective against the mutated strain.
ADVERTISING

Promote health. Save lives. Serve the vulnerable. Visit who.int






+